The COVID19 times have taught us many things and the remote work culture comes with a new experience. So, make the most of this time by making efficient use of these tools. Pick your favorite and get started!
April 26th every year marks the celebration of World Intellectual Property Day or World IP Day, and its theme for this year is “Innovate for a Green Future.https://www.kashishworld.com/blog/how-can-ip-be-a-solution-in-situations-of-crisis-like-the-covid-19-pandemic/
Coronavirus knocked on our doors and the first thing that saw its adverse effect was our corporate offices.
People started falling ill and dropping out of offices.
Lockdown was initiated and many people had to leave work.
But is that a long-term solution?Nope!By cleaning and keeping your office spotless you will just acquire an aesthetic beauty but what about infections.
For that, we need to take certain steps to make our offices germ-proof.
Here, are some of the best ways to help you with keeping your workplace employee-friendly.
According to the new market research report “COVID-19 impact on Medical Supplies Market by Type (Intubations, Personal Protective Equipment, Infusion, Radiology, Wound Care Supplies), End User (Hospitals, Clinics) – Global Forecast” published by MarketsandMarkets™.Revenue Growth Opportunities and Growth Drivers?The COVID-19 impact on the global medical supplies market is expected to reach USD ~100 billion by 2021 from an estimated value of USD ~78 billion in 2019, growing at a CAGR of ~13.4% during the forecast period.Growth Boosting Factors:Growing awareness for environmental & personal hygiene leading to rising demand of disinfectantsIncreasing number of emergency centers, hospital settings and ICUs during the PandemicIncreasing need of healthcare workers in hospitals and government camps & surveysIncreased demand of PPE kits and n95 masks globallyIncreasing demand of ventilation supplies for effective management of critical COVID-19 patientsIncreasing demand of diagnostic supplies for rapid diagnosis of COVID-19Browse 97 market data Tables and 20 Figures spread through 150 Pages and in-depth TOC – Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=158189339Market Segmentation in Detailed:Based on type, the medical supplies market is segmented into intubation and ventilation supplies, disinfectant, personal protective equipment, diagnostic supplies, sterilization supplies, infusion and injectable supplies, dialysis supplies, wound care supplies, radiology supplies, and other medical supplies.
The disinfectant segment is expected to grow at the highest CAGR during the forecast period.Based on end users, the market is segmented into hospitals, clinics, and other end-users.
The hospital segment is expected to grow at the highest CAGR owing to increasing demand for hospital beds and intensive care units in countries with the increasing incidence of COVID-19, increasing demand for specialized staff such as infectious disease experts providers, respiratory therapists, and physicians and nurses who can provide intensive and critical care, increased consumption of personnel protective equipment within the hospital premises; and the increasing support from government and non-government organization to combat with COVID-19 are the major factors driving the demand and uptake of medical supplies in hospitals growth.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158189339North America accounted for the largest share of the medical supplies market in 2020, followed by Europe.
The large share of this region is attributed mainly to a high number of positive COVID-19 cases and deaths in the US, a strong healthcare system, and the presence of many large hospitals.
Moreover, a large number of major global players are based in the US, owing to which the US can easily manufacture these devices.The prominent players in the medical supplies market are Medtronic plc (Ireland), Cardinal Health, Inc. (US), Becton, Dickson and Company (US), Johnson & Johnson (US), and B. Braun Melsungen AG (Germany), Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), STERIS Corporation (US), Getinge Group (Sweden), Advanced Sterilization Products (US), 3M Company (US), Smith & Nephew (U.K.), Mölnlycke Health Care AB (Sweden), among others.
In the latest coronavirus vaccine latest update, the US-based biotech company Moderna released new data on Monday which conclusively strengthens its case for the covid-19 vaccine.
The study stated that the moderna vaccine is 94% effective, and causes the human immune system to produce potent antibodies that endure for at least three months.Moderna Inc said that it expects between 100 million to 125 million doses of its experimental covid-19 vaccine available globally in the first quarter of 2021, in this latest covid-19 vaccine update USA.
The company added that around 85 million to 100 million of those doses would be available in the United States, while 15 million to 25 million available outside the country.The first-quarter doses are within the 500 million to up to 1 billion doses the company expects to manufacture in 2021, as per the covid-19 vaccine tracker.The vaccine, mRNA-1273, achieved high levels of binding and neutralizing antibodies in its test subjects.
Although these high levels of antibodies produced due to this covid-19 vaccine declined slightly over time, by introducing a booster vaccination the levels could be maintained high, for up to three months in all participants.The COVID-19 vaccine race:The Moderna vaccine built on the company’s previously reported findings, based on its study of about 30,000 volunteers.
In the study where both placebo and active shots were given to volunteers, only 11 of the active volunteers reported cases as opposed to the 185 cases in the placebo team.In other covid-19 vaccine news – Pfizer, which has developed a similar vaccine, reported similar findings.
Both Moderna and Pfizer vaccine showed promise in preventing severe cases.Based on these findings and the analysis of the vaccine’s safety and side-effects, Moderna has submitted an application for emergency use authorization to the food and drug administration(FDA).Pfizer applied for the same for its covid-19 vaccine on November 9.
The term “coronavirus” means a cluster of RNA viruses that causes a chain of diseases in animals as well as humans.The symptoms are as equal as the common flu, cough, and fever.
In extreme cases, this virus attacks the respiratory system which makes it deadly due to the acute breathing issues.
Mostly the elderly people and the children are on the edge as they are easy prey for this virus.
The immune system of both is a comparatively weak and easy host.
Patients are quarantined or isolated until the time they are free from the virus.Symptoms and causes of COVID-19People infected with the virus are most likely to develop flu-like symptoms such as cough, fever, shortness of breath, and fatigue.
The emergency symptoms in patients include breathing difficulty, persistent chest pain, bluish face or lips, confusion, and walking difficulty.
